• Paula M O'Shea, Graham Robert Lee, Tomás P Griffin, Vincent Tormey, Amjad Hayat, Seán J Costelloe, Damian Gerard Griffin, Saradha Srinivasan, Maurice O'Kane, Conor M Burke, John Faul, Christopher J Thompson, Gerard Curley, and William P Tormey.
• Department of Clinical Biochemistry, Saolta University Health Care Group (SUHCG), Galway University Hospitals, Newcastle Road, Galway, Ireland. PaulaM.OShea@hse.ie.
• Ir J Med Sci. 2020 Nov 1; 189 (4): 1147-1152.

IntroductionCoronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.ObjectiveTo provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.MethodsDescription of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.ResultsWe provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.ConclusionGiven the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.

18 keywords...

hide…